The publications aim to support the growing integration of AI into medical imaging and to strengthen clinicians’ ability to use these technologies safely and effectively in everyday practice.
The newly introduced AI algorithm performs measurements that radiologists previously conducted manually, significantly reducing interpretation time and improving consistency in diagnosis.
Under the agreement, Lilly will obtain exclusive worldwide rights, excluding South Korea, to develop, manufacture, and commercialise sonefpeglutide, a long-acting GLP-2 analogue.
The regulatory decision follows results from a Phase Ib study presented at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference and the 2026 International Scientific Congress on SMA Europe.
Under the agreement, Servier will take control of Edgewise Therapeutics’ muscular dystrophy portfolio, including its lead candidate sevasemten.
The newly cleared technology aims to standardize routine ultrasound examinations, reduce variability between operators, and minimize the need for repeat scans.
The new campus brings a modern approach to training healthcare professionals by embedding artificial intelligence, data analytics, and digital health tools directly into clinical learning.
Through this arrangement, Pfizer aims to accelerate the identification and design of new therapeutic candidates, particularly in areas where traditional research methods have faced limitations.
The initiative will also involve coordination with World Health Organization, Africa Centres for Disease Control and Prevention, and UNICEF to ensure alignment with national outbreak response plans and immunization priorities.
Since 2020, the Moscow government has been running the Moscow Experiment on Computer Vision in healthcare, an initiative coordinated by the Center for Diagnostics and Telemedicine with support from the city’s digital infrastructure teams.